The CFTR [CF (cystic fibrosis) transmembrane conductance regulator] chloride channel is activated by cyclic nucleotide-dependent phosphorylation and ATP binding, but also by non-phosphorylation-dependent mechanisms. Other CFTR functions such as regulation of exocytotic protein secretion are also activated by cyclic nucleotide elevating agents. A soluble protein comprising the first NBD (nucleotide-binding domain) and R-domain of CFTR (NBD1–R) was synthesized to determine directly whether CFTR binds cAMP. An equilibrium radioligand-binding assay was developed, firstly to show that, as for full-length CFTR, the NBD1–R protein bound ATP. Half-maximal displacement of [3H]ATP by non-radioactive ATP at 3.5 μM and 3.1 mM was demonstrated. [3H]cAMP bound to the protein with different affinities from ATP (half-maximal displacement by cAMP at 2.6 and 167 μM). Introduction of a mutation (T421A) in a motif predicted to be important for cyclic nucleotide binding decreased the higher affinity binding of cAMP to 9.2 μM. The anti-CFTR antibody (MPNB) that inhibits CFTR-mediated protein secretion also inhibited cAMP binding. Thus binding of cAMP to CFTR is consistent with a role in activation of protein secretion, a process defective in CF gland cells. Furthermore, the binding site may be important in the mechanism by which drugs activate mutant CFTR and correct defective ΔF508-CFTR trafficking.
Activation mechanisms for the cystic fibrosis transmembrane conductance regulator protein involve direct binding of cAMP
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
Malcolm M. C. Pereira, Jody Parker, Fiona L. L. Stratford, Margaret McPherson, Robert L. Dormer; Activation mechanisms for the cystic fibrosis transmembrane conductance regulator protein involve direct binding of cAMP. Biochem J 1 July 2007; 405 (1): 181–189. doi: https://doi.org/10.1042/BJ20061879
Download citation file: